Not so long ago (pre-Ryoncil's approval) we were looking at Ryoncil's treatment of US$300K and thought wow - that's a lot of money for insurers to pay.
Then recently, BP and Maxim up the ante to US$750K and US$800K. Following this, we didn't hear too much about pricing and doubts started to creep in - have they over estimated here?
... Today, Mesoblast announced Ryoncil treatment price of US$1.5m for kids and you would expect double for adults. 40% of adults fail Rux - no other treatment for adults who fail Rux so off-label is very likely outcome
Exciting times Enjoy the ride - our sleeping giant is finally awakening! GL MSB'ers - onwards and upwards
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)